Comparison of the thermal bone damage done by the oscillating saw and bone mill burr during total knee arthroplasty

全膝关节置换术中摆动锯和骨磨钻对骨热损伤的比较

阅读:2

Abstract

BACKGROUND: Thermal osteonecrosis from bone cutting during total knee arthroplasty (TKA) may cause aseptic implant loosening. The study compares thermal bone injury from oscillating saw (CTKA) and bone milling burr treatments (RATKA). METHOD: A prospective study comparing thermal necrosis during CTKA and RATKA was performed. The sample size (n = 36) was determined with 18 patients per group, assuming a 15 % relative increase in thermal necrosis with RATKA, with statistical thresholds set at α = 5 % and β = 10 %. The upper tibia cut surface was analyzed, with histological sections examined from 20 randomly selected fields. Thermal necrosis was evaluated by determining the proportion of non-viable cells relative to viable ones and measuring the depth from the cut bone surface at which the first intact osteocyte was observed. Statistical analysis was conducted using appropriate comparative tests, including Chi-square and t-tests, with significance determined at a threshold of p < 0.05. RESULTS: There was no significant variability in preoperative patient characteristics (gender, age, body mass index, diagnosis, range of motion, deformity and comorbidities) between CTKA (n = 18) and RATKA (n = 18) groups. The percentage of dead osteocytes at the resected surface in CTKA and RATKA were 40.3 % and 46.5 % respectively (p = 0.6309). The minimum depth where viable osteocytes were found was 25.5 ± 3.5 μmm and 27.1 ± 3.6 μmm in CTKA and RATKA respectively (p value = 0.091). CONCLUSION: Conventional TKA and RATKA produce similar thermal effects on bone, with no significant difference in osteocyte viability. This indicates that both surgical methods are comparable regarding thermal impact on bone health.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。